GÜL, A. Et Al. 2020. AN OPEN-LABEL, EXPLORATORY STUDY TO ESTABLISH THE EFFICACY AND SAFETY OF 1-YEAR CANAKINUMAB TREATMENT IN BEHCET'S DISEASE PATIENTS WITH NEUROLOGIC OR VASCULAR INVOLVEMENT. Annual European Congress of Rheumatology (EULAR) , (ELECTR NETWORK), 1533-1534.

GÜL, A., KÜRTÜNCÜ, M., Erdugan, M., OĞUZ, E., GÜNDÜZ, T., DEMİR, G., ... Sevgi, S.(2020). AN OPEN-LABEL, EXPLORATORY STUDY TO ESTABLISH THE EFFICACY AND SAFETY OF 1-YEAR CANAKINUMAB TREATMENT IN BEHCET'S DISEASE PATIENTS WITH NEUROLOGIC OR VASCULAR INVOLVEMENT . Annual European Congress of Rheumatology (EULAR) (pp.1533-1534). , ELECTR NETWORK

GÜL, Ahmet Et Al. "AN OPEN-LABEL, EXPLORATORY STUDY TO ESTABLISH THE EFFICACY AND SAFETY OF 1-YEAR CANAKINUMAB TREATMENT IN BEHCET'S DISEASE PATIENTS WITH NEUROLOGIC OR VASCULAR INVOLVEMENT," Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 2020

GÜL, Ahmet Et Al. "AN OPEN-LABEL, EXPLORATORY STUDY TO ESTABLISH THE EFFICACY AND SAFETY OF 1-YEAR CANAKINUMAB TREATMENT IN BEHCET'S DISEASE PATIENTS WITH NEUROLOGIC OR VASCULAR INVOLVEMENT." Annual European Congress of Rheumatology (EULAR) , ELECTR NETWORK, pp.1533-1534, 2020

GÜL, A. Et Al. (2020) . "AN OPEN-LABEL, EXPLORATORY STUDY TO ESTABLISH THE EFFICACY AND SAFETY OF 1-YEAR CANAKINUMAB TREATMENT IN BEHCET'S DISEASE PATIENTS WITH NEUROLOGIC OR VASCULAR INVOLVEMENT." Annual European Congress of Rheumatology (EULAR) , ELECTR NETWORK, pp.1533-1534.

@conferencepaper{conferencepaper, author={Ahmet GÜL Et Al. }, title={AN OPEN-LABEL, EXPLORATORY STUDY TO ESTABLISH THE EFFICACY AND SAFETY OF 1-YEAR CANAKINUMAB TREATMENT IN BEHCET'S DISEASE PATIENTS WITH NEUROLOGIC OR VASCULAR INVOLVEMENT}, congress name={Annual European Congress of Rheumatology (EULAR)}, city={}, country={ELECTR NETWORK}, year={2020}, pages={1533-1534} }